METHOD FOR MAKING STATISTICAL DECISIONS ABOUT CONDITIONS CAUSED BY PHARMACOLOGICAL EXPOSURE BASED ON THE MINIMUM AVERAGE RISK CRITERION

2020 ◽  
Vol 19 (2) ◽  
pp. 50-60
Author(s):  
L.L. Lyamets ◽  
A.V. Evseev ◽  
A.I. Danilov
Keyword(s):  
Average Risk ◽  
Statistical Decisions ◽  
Risk Criterion

ASSESSING THE OUTCOMES OF TREATMENT AND MANAGEMENT, 400 HYPERTENSIVE PATIENTS IN BONG SON GENERAL HOSPITAL, BINH DINH PROVINCE

2016 ◽  
pp. 31-40
Author(s):  
Long Nhon Phan ◽  
Van Minh Huynh ◽  
Thi Kim Nhung Hoang ◽  
Van Nham Truong
Keyword(s):  
Blood Pressure ◽  
Risk Stratification ◽  
Hypertensive Patient ◽  
Systolic Blood Pressure ◽  
Diastolic Blood Pressure ◽  
Blood Pressure Target ◽  
Average Risk ◽  
Hypertensive Patients ◽  
Average Systolic Blood Pressure ◽  
Complications Of Stroke

Objective: To evaluate the results of treatment achieved blood pressure goal (BP goal) and results of hypertensive patient management. Subjects and methods: A study of 400 hypertensive patient intervention, treatment and management after 2 year. To assess the results of BP target, monitor the use of medicines, the situation of hospitalization and complications of stroke. Results: Treatment: -100% of patients using diuretics and angiotensin-converting enzyme inhibitors (ACEIs), 33% of patients using angiotensin receptor blockers (ARBs), 46.25% of patients using calcium channel blockers (CCBs) and 19.5% of patients using beta-blocker. After 24 months of treatment: 50.5% of patients using 1 antihypertensive drug, 22% of patients using 2 drugs, 20.5% of patients using 3 drugs and 7% of patients taking more than 3 drugs. After 24 months of treatment: 91.75% achieved BP target and 8.25% fail. -Average risk stratification: 97.32% achieved BP target, hight risk stratification: 95.91% and very hight risk stratification: 73.03%. After 24 months of treatment. -Stage 1: 88.48% achieved BP target, stage 2: 92.85% achieved BP target and stage 3: 71.08% achieved BP target. After 24 months of treatment. -Hypertesive results before treatment were: 159.80 ± 20,22mmHg average systolic blood pressure and 82.97 ± 5,82mmHg average diastolic blood pressure. After treatment: average systolic blood pressure 125.38 ± 6,88mmHg and average diastolic blood pressure 79.83 ± 1,79mmHg. No adverse change in the index of tests about lipidemia, liver, kidney, glucomia and no recorded cases of drug side effects. Management of patients: -There were 89% non-medical examinational patients 1 month, 5.25% non-medical examinational patients 2 months, 4.25% non-medical examinational patients 3 months and 1.5% non-medical examinational patients 4 months. There were 93.5% drop pill 1 month, 3.25% drop pill 2 months, 4.25% drop pill 3 months and no patient drop pill over 3 months. In 24 months follow-up, 47% hospitalized inpatients <5 times, 44.5% hospitalized inpatients 5-10 times, 3% hospitalized inpatients 11-15 times, 4.75% hospitalized inpatients from 16-20 times and 0.75% hospitalized inpatients > 20 times. -There were 32.75% hospitalized inpatients for reasons of hypertension and 63.75% hospitalized inpatients for other common diseases. -There were a total of 11592 contacts directly by phone for medical advice, medical reminders and examinational reminders during 24 months of management. -There were 0.5% of patients stroked during 24 months of treatment and management. Conclusion: Treatment by protocol and management by phone directly for medical taking and re-examinational reminders is the best resulted method of achieving blood pressure target and reducing complications of stroke for hypertensive patients. Key word: : blood pressure target; risk stratification; treatment; management; stage; phone.

Analysis of age distribution of advanced colorectal neoplasm in average-risk Chinese

2013 ◽  
Vol 32 (4) ◽  
pp. 368-373
Author(s):  
Rong LIANG ◽  
En-da YU ◽  
Wei ZHU ◽  
Jie GAO ◽  
Zhao-shen LI ◽  
...  
Keyword(s):  
Colorectal Neoplasm ◽  
Age Distribution ◽  
Average Risk

The DEVELOPMENT OF Elaeidobius kamerunicus FAUST POPULATION AFTER INTRODUCTION AND THE IMPROVEMENT OF OIL PALM FRUIT SET IN SERAM ISLAND, MOLLUCAS, INDONESIA

2016 ◽  
Vol 24 (1) ◽  
pp. 47-55
Author(s):  
Agus Eko Prasetyo ◽  
Agus Susanto
Keyword(s):  
Sex Ratio ◽  
Oil Palm ◽  
Fruit Set ◽  
Average Risk ◽  
Palm Fruit ◽  
Male And Female ◽  
Risk Of Death ◽  
North Sumatra ◽  
Female Flowers ◽  
Elaeidobius Kamerunicus

Elaeidobius kamerunicus is the main pollinating agent in oil palm plantations in Indonesia today. The development of oil palm plantations in new areas requires introduction of these insects, moreover the new areas are located on different islands. First introduction of Elaeidobius kamerunicus Faust had been done from North Sumatra to Seram Island on 23 September 2013. The introduction was performed on larva and pupa stadium in 4-5 days post anthesising of male inflorescences. The introduction of E. kamerunicus using plywood boxes has an average risk of death by 7.89% at 6 days delivery period. Observation before releasing of the weevils showed that this insect was not detected in both of oil palm male and female flowers and the oil palm fruit set was very low approximately 11.27%. For about 500 weevils/ha were released in Marnuhu estate and could be developed into 362,401 weevils/ha in 5 months with 97.86% of oil palm sex ratio. The oil palm fruit sets were increased after 1 and 2 months introduction, 53.70% and 75.56 %, respectively. The lower sex ratio of oil palm or the more availability of male inflorescences make growth of E. kamerunicus population became faster and the greater number of weevils that visiting anthesising of female flowers make the higher value of oil palm fruit set.

The DEVELOPMENT OF Elaeidobius kamerunicus FAUST POPULATION AFTER INTRODUCTION AND THE IMPROVEMENT OF OIL PALM FRUIT SET IN SERAM ISLAND, MOLLUCAS, INDONESIA

2018 ◽  
Vol 24 (1) ◽  
pp. 47-55
Author(s):  
Agus Eko Prasetyo ◽  
Agus Susanto
Keyword(s):  
Sex Ratio ◽  
Oil Palm ◽  
Fruit Set ◽  
Average Risk ◽  
Palm Fruit ◽  
Male And Female ◽  
Risk Of Death ◽  
North Sumatra ◽  
Female Flowers ◽  
Elaeidobius Kamerunicus

Elaeidobius kamerunicus is the main pollinating agent in oil palm plantations in Indonesia today. The development of oil palm plantations in new areas requires introduction of these insects, moreover the new areas are located on different islands. First introduction of Elaeidobius kamerunicus Faust had been done from North Sumatra to Seram Island on 23 September 2013. The introduction was performed on larva and pupa stadium in 4-5 days post anthesising of male inflorescences. The introduction of E. kamerunicus using plywood boxes has an average risk of death by 7.89% at 6 days delivery period. Observation before releasing of the weevils showed that this insect was not detected in both of oil palm male and female flowers and the oil palm fruit set was very low approximately 11.27%. For about 500 weevils/ha were released in Marnuhu estate and could be developed into 362,401 weevils/ha in 5 months with 97.86% of oil palm sex ratio. The oil palm fruit sets were increased after 1 and 2 months introduction, 53.70% and 75.56 %, respectively. The lower sex ratio of oil palm or the more availability of male inflorescences make growth of E. kamerunicus population became faster and the greater number of weevils that visiting anthesising of female flowers make the higher value of oil palm fruit set.

scholarly journals Pharmacologic and non-pharmacologic interventions to prevent hypersensitivity reactions of non-ionic iodinated contrast media: a systematic review protocol

BMJ Open ◽  
2020 ◽  
Vol 10 (3) ◽  
pp. e033023
Author(s):  
Hiroyasu Umakoshi ◽  
Takashi Nihashi ◽  
Hironori Shimamoto ◽  
Takehiro Yamada ◽  
Hiroaki Ishiguchi ◽  
...  
Keyword(s):  
Contrast Media ◽  
Assessment Tools ◽  
Average Risk ◽  
Cochrane Central Register ◽  
Hypersensitivity Reactions ◽  
Iodinated Contrast Media ◽  
Preventive Interventions ◽  
Validity Assessment ◽  
Iodinated Contrast ◽  
Standard Design

IntroductionIodinated contrast media are commonly used in medical imaging and can cause hypersensitivity reactions, including rare but severe life-threatening reactions. Although several prophylactic approaches have been proposed for severe reactions, their effects remain unclear. Therefore, we aim to review systematically the preventive effects of pharmacologic and non-pharmacologic interventions and predictors of acute, hypersensitivity reactions.Methods and analysisWe will search the PubMed, EMBASE and Cochrane Central Register of Controlled Trials databases from 1 January 1990 through 31 December 2019 and will examine the bibliographies of eligible studies, pertinent review articles and clinical practice guidelines. We will include prospective and retrospective studies of any design that evaluated the effects of pharmacological and non-pharmacological preventive interventions for adverse reactions of non-ionic iodinated contrast media. Two assessors will independently extract the characteristics of the study and intervention and the quantitative results. Two independent reviewers will assess the risk of bias using standard design-specific validity assessment tools. The primary outcome will be reduction in acute contrast media-induced hypersensitivity reactions. The secondary outcomes will include characteristics associated with the development of contrast media-induced acute hypersensitivity reactions, and adverse events associated with specific preventive interventions. Unique premedication regimens (eg, dose, drug and duration) and non-pharmacological strategies will be analysed separately. Average-risk and high-risk patients will be considered separately. A meta-analysis will be performed if appropriate.Ethics and disseminationEthics approval is not applicable, as this will be a secondary analysis of publicly available data. The results of the analysis will be submitted for publication in a peer reviewed journal.PROSPERO registration numberCRD42019134003

Sign in / Sign up

Export Citation Format

Share Document